Dana Investment Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-30,801
| Closed | -$473K | – | 421 |
|
|
2023
Q2 | $473K | Buy |
30,801
+6,390
| +26% | +$98.2K | 0.02% | 328 |
|
|
2023
Q1 | $549K | Sell |
24,411
-949
| -4% | -$21.3K | 0.03% | 301 |
|
|
2022
Q4 | $533K | Buy |
25,360
+5,850
| +30% | +$123K | 0.03% | 304 |
|
|
2022
Q3 | $481K | Sell |
19,510
-876
| -4% | -$21.6K | 0.03% | 308 |
|
|
2022
Q2 | $494K | Sell |
20,386
-489
| -2% | -$11.9K | 0.03% | 311 |
|
|
2022
Q1 | $538K | Sell |
20,875
-173
| -0.8% | -$4.46K | 0.02% | 264 |
|
|
2021
Q4 | $653K | Sell |
21,048
-2,364
| -10% | -$73.3K | 0.03% | 242 |
|
|
2021
Q3 | $568K | Buy |
+23,412
| New | +$568K | 0.03% | 239 |
|